Release Date: 19/11/13 13:33 Summary: Sale of Molopo's assets in Saskatchewan, Canada Price Sensitive: Yes Download Document 149.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%